Biochemical and pharmacological characterization of 1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline: A biologically relevant neurotoxin?

European Journal of Pharmacology

Volumn 442, Issue 1-2, 2002, Pages 1-16

  Riederer, Peter ^a   Foley, Paul ^a   Bringmann, Gerhard ^a   Feineis, Doris ^a   Brückner, Ralph ^a   Gerlach, Manfred ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

(MPTP) 1 Methyl 4 phenyl 1,2,3,6 tetrahydropyridine; (TaClo) 1 Trichloromethyl 1,2,3,4 tetrahydro carboline; Carboline; Neurotoxin; Parkinson's disease

Indexed keywords

1 TRICHLOROMETHYL 1,2,3,4 TETRAHYDRO BETA CARBOLINE; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 2,3 DIHYDROXYBENZOIC ACID; 3,4 DIHYDROXYPHENYLACETIC ACID; 4 AMINOBUTYRIC ACID; ALCOHOL; ARYLSULFATASE; BETA GLUCURONIDASE; CARBOLINE DERIVATIVE; CHLORAL HYDRATE; GLUTAMIC ACID; HYDROXYL RADICAL; N METHYL 1 TRICHLOROMETHYL 1,2,3,4 TETRAHYDRO BETA CARBOLINE; NEUROTOXIN; SEROTONIN; TRICHLOROETHYLENE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; CARCINOGENICITY; CELL DENSITY; DEGENERATIVE DISEASE; DOPAMINERGIC SYSTEM; DRUG DISTRIBUTION; DRUG EFFECT; DRUG METABOLISM; DRUG SYNTHESIS; EXPOSURE; HUMAN; MITOCHONDRION; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; POLLUTION; PRIORITY JOURNAL; RADIOACTIVITY; REVIEW; SEROTONINERGIC SYSTEM; WORKPLACE;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; CARBOLINES; HUMANS; MITOCHONDRIA; MOTOR ACTIVITY; NEUROTOXINS; OXYGEN CONSUMPTION; SEROTONIN; TISSUE DISTRIBUTION;

EID: 0037012733     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)01308-0     Document Type: Review

References (89)

1. β-Carbolines, psychoactive compounds in the mammalian body: Part I. Occurrence, origin and metabolism
2. β-Carbolines, psychoactive compounds in the mammalian body: Part II. Effects
3. Mitochondrial respiratory inhibition by N-methylated β-carboline derivatives structurally resembling N-methyl-4-phenylpyridine
4. Solvents and other industrial organic compounds
5. Functionally selective neurochemical afferents and efferents of the mesocorticolimbic and nigrostriatal dopamine systems
6. Environmental and genetic factors in the etiology of Parkinson's disease
7. Inhibition of glutamate transport in synaptosomes by dopamine oxidation and reactive oxygen species
8. Neuropsychological impairment among former microelectronic workers
9. Nigral and extranigral pathology in Parkinson's disease
10. Chemische Mechanismen der Alkohol-Wirkung
11. 1-Trichloromethyl-1,2,3,4-tetrahydro-β-carboline - A potential chloral-derived indol alkaloid in man
12. Endogene Alkaloide im Säugerorganismus
13. Potential tryptophan-derived alkaloids in chloral-treated patients: Synthesis and stereostructure
14. Trichloroharmanes as potential endogenously formed inducers of Morbus Parkinson: Synthesis, analytics, and first in vivo-investigations
15. The TaClo concept: 1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline (TaClo), a new toxin for dopaminergic neurons
16. TaClo as a neurotoxic lead: Improved synthesis, stereochemical analysis, and inhibition of the mitochondrial respiratory chain
17. Neurotoxic effects on the dopaminergic system induced by TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline), a potential mammalian alkaloid: In vivo and in vitro studies
18. Endogenous alkaloids in man: XXVI. Determination of the dopaminergic neurotoxin 1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline (TaClo), in biological samples using gas chromatography with selected ion monitoring
19. Identification of the dopaminergic neurotoxin 1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline in human blood after intake of the hypnotic chloral hydrate
20. Bromal-derived tetrahydro-β-carbolines as neurotoxic agents: Chemistry, impairment of the dopamine metabolism, and inhibitory effects on mitochondrial respiration
21. Effect of 1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline (TaClo) on human serotonergic cells
22. Mammalian alkaloids II
23. Metabolism, toxicity and carcinogenicity of trichloroethylene
24. Blood and urine concentrations of chemical pollutants in the general populations
25. Health effects of environmental contaminant exposure: An intrafile comparison of the Trichloroethylene Subregistry
26. A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
27. Alcohol, amines and alkaloids: A possible biochemical basis for alcohol addiction
28. Chronic parkinsonism secondary to intravenous injection of meperidine analogues
29. Tissue distribution of trichloroethylene and its metabolites in a forensic case
30. Halogenated cyclic hydrocarbons
31. Dopamine uptake inhibitory capacities of β-carboline and 3,4-dihydro-β-carboline analogs of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) oxidation products
32. Species- and sex-related differences in metabolism of trichloroethylene to yield chloral and trichloroethanol in mouse, rat and human liver microsomes
33. Trichloroethylene
34. Long-term follow-up after single toxic exposure to trichloroethylene
35. Animal models of Parkinson's disease: An empirical comparison with the phenomenology of the disease in man
36. MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease
37. N-Methyl-(R)-salsolinol and its relevance to Parkinson's disease
38. 1-Trichloromethyl-1,2,3,4-tetrahydro-β-carboline increases extracellular serotonin and stimulates hydroxyl radical production in rats
39. Neurotoxic and neurobehavioural effects of organic solvents on the nervous system
40. Biochemical lesions of the nigrostriatal system induced by TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline) and derivatives
41. Trichloroethylene and parkinsonism: A human and experimental observation
42. The halogenated tetrahydro-β-carboline "TaClo": A progressively acting neurotoxin
43. Neurotoxicity of endogenous tryptamine and chloral?
44. Trichloroethylene affects learning and decreases myelin in the rat hippocampus
45. 1-Trichloromethyl-1,2,3,4-tetrahydro-β-carboline, a new inhibitor of complex I
46. Effect of highly halogenated β-carbolines on dopaminergic cells in culture and on mitochondrial respiration
47. Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway
48. + induced neurotoxicity in rodents and the common marmoset as experimental models for investigating Parkinson's disease
49. Assessment of the health effects of trichloroethylene
50. Kinetics of trichloroethylene elimination from venous blood after acute inhalation poisoning
51. +)
52. Untersuchungen zu Plasmaspiegeln des Neurotoxins 1-Trichlormethyl 1,2,3,4 tetrahydro-β-carbolin (TaClo) beim Menschen nach oraler Verabreichum von Chloralhydrat
53. Chronic effects of trichloroethylene exposure
54. Psychological prognosis of diagnosed chronic organic solvent intoxication
55. Potential bioactivated neurotoxicants, N-methylated β-carbolinium ions, are present in human brain
56. Trichloroethylene in trigeminal anaesthesia
57. Industrial gassing poisonings due to trichloroethylene, perchlorethylene and 1,1,1-trichloroethane, 1961-1980
58. 3H]dopamine uptake into striatal synaptosomes by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
59. The route and significance of endogenous synthesis of alkaloids in animals
60. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease
61. Ferrous-citrate complex and nigral degeneration: Evidence for free radical formation and lipid peroxidation
62. Metabolism of trichloroethylene in man: III. Interaction of trichloroethylene and ethanol
63. Isoquinolines, beta-carbolines and alcohol drinking: Involvement of opioid and dopaminergic mechanisms
64. +)
65. +
66. Simultaneous monitoring of dopamine release in rat frontal cortex, nucleus accumbens and striatum: Effect of drugs, circadian changes and correlations with motor activity
67. Trichloroethene levels in human blood and exhaled breath from controlled inhalation exposure
68. Hypnotics and sedatives; Ethanol
69. Energy-driven uptake of N-methyl-4-phenylpyridine by brain mitochondria mediates the neurotoxicity of MPTP
70. Studies of the potentially endogenous toxin TaClo (1-trichloromethylene-1,2,3,4-tetrahydro-β-carboline) in neuronal and glial cell cultures
71. Excretion of tetrahydroharmane and harmane into the urine of man and rat after load with alcohol
72. Ethanol induces an increase of harman in the brain and urine of rats
73. Dopaminergic neurotoxicity in vivo and inhibition of mitochondrial respiration in vitro by possible endogenous pyridinium-like substances
74. Mitochondrial complex I deficiency in Parkinson's disease
75. Interaction of chloral hydrate and ethanol in man: II. Hemodynamics and performance
76. Progressive changes in striatal dopaminergic markers, nigral volume and rotational behavior following iron infusion into rat substantia nigra
77. Parkinson's disease: A major hypokinetic basal ganglia disorder
78. Methodological approach to the evaluation of neurotoxicity data and the classification of neurotoxic chemicals
79. Long-term behavioural effects of TaClo (1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline) after subchronic treatment in rats
80. Early clinical neurochemistry of CNS-active drugs. Chloral hydrate
81. Environmental agents and Parkinson's disease
82. An expanded classification of neurotoxic responses based on cellular targets of chemical agents
83. Trichloroethylen in Lebensmitteln, Bundesgesundheitsbl
84. Indole derivatives as neuroprotectants
85. Selective inhibition of complex I by N-methylisoquinolinium ion and N-methyl-1,2,3,4-tetrahydroisoquinoline in isolated mitochondria prepared from mouse brain
86. Alcohol intoxication in teenagers using inhalant stupefacients
87. Functional studies on monoaminergic transmitter release in parkinsonism
88. Intranigral injected iron progressively reduces striatal dopamine metabolism
89. Hazardous waste and neurobehavioral effects: A developmental perspective